HAIRO Hair Transplant Robot: China's First NMPA Class III-Certified AI-Powered Solution Revolutionizing the Hair Restoration Industry

A transformation shaping the future of China’s hair transplant industry has quietly begun. On March 1, 2025, Bangce Medical held its HAIRO event, themed “Bangzhi Qiyuan, Cefa Xinpian” (Pioneering Intelligence, Strategizing a New Chapter), in Shanghai’s G60 Science and Technology Innovation Corridor.^®Hair Transplant Robot Launch Event.

HAIRO, the first hair transplant robot approved for market launch in China and the top one in Asia, independently developed by Bangce Medical^®Centered on proprietary Chinese algorithms, the hair transplant robot integrates an intelligent hand-eye coordinated operating system with AI-assisted visual recognition technology. By overcoming the precision limitations of traditional manual procedures, it establishes a comprehensive solution encompassing “precise identification, dynamic planning, and intelligent manipulation.” This innovation holds promise for addressing critical challenges in the current hair transplant industry, including scarcity of medical professionals, lack of standardization, severe homogenization, and high marketing costs. It aims to help hair transplant institutions reshape their core competitiveness, achieve dual upgrades in reputation and brand value, and propel the hair health industry from experience-driven to digital-driven development.

Yu Jian, former Deputy Director of the Department of Strategic Planning under the former Ministry of Science and Technology; Wang Yu, Deputy Director of Shanghai Shenkang Hospital Development Center; Sun Lining, Foreign Member of the Russian Academy of Engineering and Dean of the School of Mechanical and Electrical Engineering at Soochow University; Wu Wenyu, Director of the Department of Dermatology at Huashan Hospital Affiliated to Fudan University; Cheng Yunzhang, Director of the Medical Device Innovation Center in Lingang New Area; Zhang Jufang, Director of the Department of Plastic Surgery at Hangzhou First People’s Hospital Affiliated to Westlake University; Yang Dingquan, Head of the Hair Medicine Consortium at China-Japan Friendship Hospital;Li Ming, Founder of Zhongzhi Medical Group,Cui Shaofang, Executive Director and Deputy Chief Executive Officer of Damai Micro-needle Hair Transplantation, Zhang Zhaodong, Founder of Bangce Medical, and dozens of other representatives from the government, industry, academia, research, medical, and investment sectors jointly witnessed this moment of technological leap in the hair transplantation industry.

Technological innovation has become the primary arena for international strategic competition. Although domestically produced surgical robots have made significant breakthroughs in serious medical fields such as orthopedics and vascular surgery, there is a notable gap in the consumer healthcare sector, particularly in the hair transplantation field where demand is surging. Hair transplantation institutions urgently need to leverage intelligent technologies to enhance technical precision and surgical efficiency, while reducing operational costs and the financial burden on patients.

“Poundce Medical’s domestically developed first intelligent hair transplant robot has successfully broken the U.S. monopoly in this field, marking a major breakthrough in China’s surgical robotics development and providing an intelligent solution for the vast population suffering from hair loss.” Yu Jian, former Deputy Director of the Strategic Planning Department of the Ministry of Science and Technology, affirmed Poundce Medical’s achievements, stating that the nation’s first hair transplant robot embodies the dedication of researchers and demonstrates China’s firm resolve and strong capabilities in pursuing independent technological innovation.

Yu Jian, Former Deputy Director of the Department of Strategic Planning under the former Ministry of Science and Technology

Academician Sun Lining, Dean of the School of Mechanical and Electrical Engineering at Soochow University and Deputy Director of the State Key Laboratory of Robotics and Systems at Harbin Institute of Technology, remarked that the Bangce Hair Transplantation Robot project, leveraging the technological expertise accumulated by HIT’s robotics system and developed in collaboration with Professor Wu Wenyu’s dermatology team at Huashan Hospital affiliated to Fudan University, stands as a paradigmatic example of industry-academia partnership and co-creation.

Academician Sun Lining, Dean of the School of Mechanical and Electrical Engineering at Soochow University and Deputy Director of the State Key Laboratory of Robotics and Systems at Harbin Institute of Technology

Professor Wu Wenyu, Director of the Department of Dermatology at Huashan Hospital Affiliated to Fudan University, pointed out that HAIRO^®The hair transplant robot deeply integrates AI, robotics, and innovative conceptual frameworks to address the industry’s challenges of high labor intensity and energy consumption, thereby enhancing surgical precision and follicular unit survival rates. Capable of extracting 1,800 follicular units per hour, its performance surpasses that of comparable foreign products. The application of this system helps improve surgeons’ technical skills and efficiency, shortens training periods, facilitates the adoption of hair transplant services in public hospitals, and accelerates the standardization and homogenization of hair transplant capabilities.

Professor Wu Wenyu, Director of the Department of Dermatology, Huashan Hospital Affiliated to Fudan University

Zhang Zhaodong, Founder of Bangce Medical, Provides an In-Depth Analysis of HAIRO^®The “Intelligent Manufacturing in China” Technological Core of Hair Transplant RobotsBy integrating binocular vision, depth vision, and infrared light source technologies with a head dynamic tracking system, and supported by an AI computing platform with three times the processing power of comparable imported systems, the robot achieves six intelligent path planning iterations prior to puncture and enables synchronized hand-brain control. Its 6+3 degrees-of-freedom robotic arm transcends ergonomic limitations, allowing for the continuous, high-precision extraction of high-quality hair follicles. Operationally, it simplifies traditionally complex procedures through a standardized three-step process, while employing sterilized disposable consumables with unique “one kit, one code” identification to ensure full-process traceability management.

Zhang Zhaodong, Founder of Bangce Medical

While filling the gap in domestically produced hair transplant robots, Pangce Medical has also formulated the industry’s first White Paper on the Construction of a Standardized System for Hair Transplant Robots and simultaneously launched the “Hair Transplant Physician Training Program.”

White Paper on the Standardization System for Hair Transplant Robots was jointly initiated by Bangce Medical, Huashan Hospital Affiliated to Fudan University, and other public hospitals, industry associations, and renowned private institutions. For the first time, this white paper systematically outlines a comprehensive standard framework for the entire clinical application process of hair transplant robots based on practical implementation. It not only fills the gap in domestic technical specifications but also provides the industry with reusable technical benchmarks and safety standards, promoting the transition of hair transplant surgery from reliance on physician experience to data-driven precision, and facilitating the industry’s comprehensive upgrade toward intelligence, efficiency, and standardization.

The “Hair Transplant Physician Training Program” collaborates with multiple hospitals, including Huashan Hospital Affiliated to Fudan University, Peking University Shougang Hospital, Hangzhou Plastic Surgery Hospital, and Shanghai 411 Hospital, as well as renowned industry associations. By adopting a model that combines “theoretical instruction + hands-on training + clinical mentorship,” the program accelerates the cultivation of hair transplant specialists and promotes the widespread adoption of “AI-assisted hair transplantation” technology. Through systematic training, it rapidly expands the base of qualified physicians, breaking the traditional reliance on “star doctors” in hair transplantation and accelerating the dissemination of high-quality hair transplant resources. Physicians trained under this program serve not only as practitioners of the technology but also as brand ambassadors, with high-standard surgical outcomes facilitating positive word-of-mouth among patients.

For private institutions, hair transplant robots bring not only tool upgrades but also a restructuring of business models, enabling them to shift from "exchanging scale for profit" to "creating value through technology." Most hair transplant medical institutions are trapped in a vicious cycle of "low prices for traffic, high energy consumption, and low profits." However, the average payback period for using hair transplant robots is only six months. Moreover, intelligent services highlighted by "precision and high survival rates" provide new leverage points for brand premium and increasing average customer spending.

For public hospitals, hair transplant robots can help general physicians reach expert-level proficiency more quickly, effectively alleviating the shortage of specialist resources and significantly enhancing service capacity. As surgical quality and patient volume increase, the brand competitiveness and reputation of public hospitals will strengthen, attracting more patients and fostering a virtuous cycle of development. Particularly in the current context where hospitals are responsible for their own profits and losses, this technology is poised to become a new growth driver for hospital revenue.

By establishing industry standards and training programs, Pangce Medical has completed its transformation from achieving breakthroughs at individual points to leading the ecosystem, and from being an equipment supplier to becoming a builder of the industry ecosystem.

Technological innovation often drives industry transformation. The advent of hair transplant surgical robots has not only restructured the underlying logic of traditional hair transplant procedures but also provided hair transplant institutions with a clear path toward intelligent and standardized upgrades. Despite HAIRO^®The hair transplant robot went from approval to market launch in just two months, yet it has already been firmly chosen by some medical institutions.

At the press conference, Bangce Medical announced partnerships with Zhongzhi Medical Group, Meibei Medical Aesthetics, Damai Micro-needle Hair Transplant, and Anhui Meifu Medical. This comprehensive ecosystem alliance, encompassing “technology enablers, industry benchmarks, traffic hubs, and regional leaders,” aims to reshape the value chain of the hair transplant industry through intelligence-driven innovation.

China’s hair transplant market has surpassed RMB 20 billion in size, serving over one million people annually, yet its market penetration rate stands at only 0.5%. Private institutions constitute the main force in the hair transplant market, accounting for approximately 86%, but they face structural dilemmas characterized by “large scale but limited strength”: scarcity of physician resources, insufficient standardization, severe homogenization, and high marketing costs. Li Ming, Chairman of Zhongzhi Medical Group, stated that HAIRO^®Hair transplant robots are not merely tools for cost reduction and efficiency enhancement, but also a lever for brand upgrading. They not only achieve dual breakthroughs in physician training and hair transplant efficiency, but also make the hair transplant industry more transparent through data standardization and traceability. Furthermore, hair transplant robots can help clinics build differentiated core competencies, reduce marketing costs, and improve profit margins.

The strategic partnership with Zhongzhi Medical Group marks the recognition of Pangce’s technological roadmap by leading industry institutions. As a pioneer in China’s hair restoration medical sector, Zhongzhi Medical Group has chosen to collaborate with Pangce to develop a comprehensive “AI + Hair Transplant” solution across all scenarios, and has taken the lead in procuring multiple HAIRO units.^®Hair Transplant Robots standardize and replicate expert-level hair transplantation techniques across all brands under the group, addressing core pain points such as high labor costs and the non-replicability of physicians’ skills. By reshaping industry competition logic through a value triangle of “efficiency-quality-brand,” these robots enable hair transplant institutions to move away from “price wars” and return to rational business practices. The deep strategic cooperation between Zhongzhi Medical Group and Bangce Medical not only signifies comprehensive endorsement by domestic leaders in the hair transplantation field for innovative technological approaches but also reveals the comprehensive transformation of the medical service industry towards digitalization and intelligence.

The strategic partnership with Meibei Medical Aesthetics has opened up a new path of “joint traffic operation + ecosystem co-construction.” Both parties will leverage diverse channels—including influencers, bloggers, physician IPs, and advertising campaigns—to deploy comprehensive content across multiple platforms such as Xiaohongshu (Little Red Book), Weibo, and Douyin. By conducting precise user persona analysis, guiding aesthetic medicine consumption decisions, and disseminating industry-focused educational content, they aim to jointly build an end-to-end pathway that spans from demand activation to trust in medical technologies. This initiative seeks to drive the hair transplantation industry’s transition from “information-asymmetric consumer decision-making” to “technology-driven precision medicine,” ultimately achieving a multi-party win-win scenario characterized by “stimulated user demand, enhanced institutional efficiency, and upgraded industry value.”

The strategic partnership with Damai Micro-Needle Hair Transplantation has pioneered a paradigm for the intelligent transformation of chain hair transplant institutions. Damai Micro-Needle Hair Transplantation will deploy HAIRO^®Hair transplant robots are deployed to core clinics, integrating a full-chain service system of “intelligent detection–precise planning–standardized surgery” into daily operations. This directly addresses the expansion bottlenecks caused by heavy reliance on physician resources in chain hair transplant institutions, as well as quality control challenges stemming from variability in manual procedures, thereby achieving consistent service quality across thousands of locations. Meanwhile, it validates a replicable pathway for the industry wherein technological decentralization does not compromise quality and large-scale expansion remains under control. By assigning standardized procedural steps to robots, physicians can focus on designing treatment plans for complex cases and optimizing postoperative aesthetics, driving institutional transformation from “labor-intensive services” to “technology-enabled value-added medical care.”

The partnership with Anhui Meifu Medical focuses on deepening regional market penetration and decentralizing advanced technologies. By leveraging localized medical resource advantages, it establishes a dual-track model of “premium technology + accessible services.” Relying on the AI algorithms of hair transplantation robots to address the diagnostic and therapeutic capabilities gaps in primary care institutions, this approach eliminates service radius constraints and geographical limitations of physician resources imposed by technical barriers. This enables regional institutions to deliver high-end hair transplantation services comparable to those in first-tier cities, thereby helping them strengthen their core competitiveness.

The era of “empiricism” is now behind us. At this moment, the hair transplantation industry stands at a new historical juncture marked by the deep integration of “precision medicine” and “inclusive healthcare.” The widespread adoption of hair transplantation robots will rectify industry irregularities, elevate overall industry standards, and restore patient confidence and trust in the sector.

From individual technological breakthroughs to a comprehensive ecosystem loop, and from physician training to commercial implementation, the light of “Pangzhi” is illuminating the path of medical innovation, while the power of “Cefa” is reshaping the future of hair health. As the bottleneck of expert resources in public hospitals is alleviated by hair transplant robots, and the profitability challenges faced by private institutions are overcome through intelligent solutions, a new era of hair transplantation—led by high-end domestically produced equipment and co-created with ecosystem partners—has arrived. The “top priority” challenge facing 250 million people suffering from hair loss is now seeing the dawn of a breakthrough.